Reports for CHEPLAPHARM ARZNEIMITTEL GMBH
Company Name
CHEPLAPHARM ARZNEIMITTEL GMBH
Totals |
||
Shortage reports |
48 |
|
Actual shortage: | 4 (8%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 1 (2%) | |
Resolved: | 43 (90%) | |
Discontinuation Reports |
7 |
|
To be discontinued: | 1 (14%) | |
Discontinued: | 6 (86%) | |
Reversed: | 0 (0%) | |
Late reports |
4 (7%) |
|
Overdue reports |
3 (60%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
SUPREFACT | 1MG | SOLUTION | Resolved | 2017-05-12 | 2017-07-06 | 10149 |
ANANDRON | 50MG | TABLET | Resolved | 2017-06-21 | 2017-07-06 | 13478 |
FUNGIZONE | 50MG | POWDER FOR SOLUTION | Resolved | 2017-07-20 | 2019-05-23 | 16534 |
RIVOTRIL | 0.5MG | TABLET | Resolved | 2017-11-07 | 2017-12-13 | 28573 |
HYDREA | 500MG | CAPSULE | Resolved | 2017-12-13 | 2018-04-19 | 32737 |
RIVOTRIL | 0.5MG | TABLET | Resolved | 2018-01-03 | 2018-04-21 | 34871 |
HYDREA | 500MG | CAPSULE | Resolved | 2018-01-30 | 2018-03-16 | 37624 |
VEPESID | 50MG | CAPSULE | Avoided shortage | 2018-05-16 | 2018-12-20 | 49573 |
ONE-ALPHA | 2MCG | LIQUID | Resolved | 2018-09-07 | 2019-04-22 | 60235 |
INHIBACE | 2.5MG | TABLET | Actual shortage | 2018-11-26 | 2019-02-19 | 67581 |
VEPESID | 50MG | CAPSULE | Resolved | 2018-12-20 | 2019-07-05 | 70228 |
SUPREFACT | 1MG | SOLUTION | Resolved | 2019-05-02 | 2019-06-04 | 83015 |
HYDREA | 500MG | CAPSULE | Resolved | 2019-08-06 | 2020-07-01 | 90891 |
ANANDRON | 50MG | TABLET | Resolved | 2019-11-21 | 2019-12-16 | 99378 |
SUPREFACT | 1MG | SOLUTION | Resolved | 2020-01-30 | 2020-02-19 | 104798 |
ONE-ALPHA | 1MCG | CAPSULE | Resolved | 2020-04-04 | 2020-05-16 | 110953 |
INHIBACE | 5MG | TABLET | Resolved | 2020-05-13 | 2021-10-19 | 114894 |
HYDREA | 500MG | CAPSULE | Resolved | 2020-07-28 | 2020-10-15 | 121262 |
VISUDYNE | 15MG | POWDER FOR SOLUTION | Resolved | 2020-08-31 | 2022-02-11 | 123386 |
INHIBACE PLUS | 5MG 12.5MG | TABLET | Resolved | 2021-01-04 | 2021-10-19 | 130792 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
LOSEC | 20MG | TABLET (DELAYED-RELEASE) | Discontinued | 2021-11-19 | 2021-11-19 | 149669 |
SUPREFACT | 100MCG | SOLUTION | Discontinued | 2021-12-13 | 2021-12-13 | 151039 |
XELODA | 150MG | TABLET | Discontinued | 2022-11-30 | 2022-12-01 | 176355 |
XELODA | 500MG | TABLET | Discontinued | 2022-11-30 | 2022-12-01 | 176359 |
ANANDRON | 50MG | TABLET | Discontinued | 2024-05-16 | 2024-05-17 | 228155 |
SUPREFACT DEPOT 3 MONTHS | 9.45MG | IMPLANT | Discontinued | 2024-05-16 | 2024-05-17 | 228166 |
SUPREFACT DEPOT 2 MONTHS | 6.3MG | IMPLANT | To be discontinued | 2024-05-16 | 2024-06-03 | 228169 |
Showing 1 to 7 of 7